Neonatal priming and infancy boosting with a novel respiratory syncytial virus vaccine induces protective immune responses without concomitant respiratory disease upon RSV challenge

Although respiratory syncytial virus (RSV) infection in infants and young children is a global public health issue, development of a safe RSV vaccine has been impeded by formalin-inactivated RSV-enhanced respiratory disease (ERD). In developing a safer yet effective RSV vaccine for children, a strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shuren, Zhao, Gan, Su, Caixia, Li, Chaofan, Zhou, Xian, Zhao, Weidong, Zhong, Yiwei, He, Zhonghuai, Peng, Haichang, Dong, Aihua, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227690/
https://www.ncbi.nlm.nih.gov/pubmed/31545125
http://dx.doi.org/10.1080/21645515.2019.1671134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227690/
https://www.ncbi.nlm.nih.gov/pubmed/31545125
http://dx.doi.org/10.1080/21645515.2019.1671134

Ejemplares similares